Literature DB >> 17934056

Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene.

He Li1, Jun-Ping Liu.   

Abstract

Transforming growth factor-beta (TGF-beta) induces cell differentiation and suppresses cell proliferation, but the mechanisms underlying the actions of TGF-beta remain to be fully elucidated. Recent studies suggest that TGF-beta suppresses neoplastic cell development by employing Smad3 protein to repress the gene of human telomerase reverse transcriptase (hTERT). In human breast cancer cells, TGF-beta induces rapid phosphorylation and subsequent entry of Smad3 into the nucleus. In the nucleus, Smad3 binds to the hTERT gene promoter directly and inhibits hTERT gene transcription activity. By interacting with c-myc, Smad3 also represses the c-myc gene. Thus, TGF-beta prevents continuous cell proliferation by switching off telomerase activity through Smad3 repression of the hTERT gene and the action of c-myc. Modulating the interface between Smad3 and the hTERT gene, and the potential feedback loop from telomeres to Smad3 via Smurf2, may represent a novel approach to regulate cell lifespan of proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934056     DOI: 10.1196/annals.1396.016

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

Review 1.  The role of activin in mammary gland development and oncogenesis.

Authors:  Karen A Dunphy; Alan L Schneyer; Mary J Hagen; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-08       Impact factor: 2.673

Review 2.  Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.

Authors:  Jiyue Zhu; Yuanjun Zhao; Shuwen Wang
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

3.  Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.

Authors:  Yuan Yao; Marcia Bellon; Shary N Shelton; Christophe Nicot
Journal:  J Biol Chem       Date:  2012-04-10       Impact factor: 5.157

4.  Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.

Authors:  Nikolaos Stefanou; Vassilis Papanikolaou; Yoichi Furukawa; Yusuke Nakamura; Aspasia Tsezou
Journal:  BMC Cancer       Date:  2010-08-19       Impact factor: 4.430

5.  Gene therapy of Cav1.2 channel with VIP and VIP receptor agonists and antagonists: a novel approach to designing promotility and antimotility agents.

Authors:  Xuan-Zheng Shi; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-08       Impact factor: 4.052

6.  Evidence for activation of the TGF-beta1 promoter by C/EBPbeta and its modulation by Smads.

Authors:  Selvajothi Abraham; Thersa Sweet; Kamel Khalili; Bassel E Sawaya; Shohreh Amini
Journal:  J Interferon Cytokine Res       Date:  2009-01       Impact factor: 2.607

7.  The Splicing Factor SRSF1 as a Marker for Endothelial Senescence.

Authors:  Francisco Javier Blanco; Carmelo Bernabéu
Journal:  Front Physiol       Date:  2012-03-28       Impact factor: 4.566

8.  Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans.

Authors:  Massimo Mangino; Shih-Jen Hwang; Timothy D Spector; Steven C Hunt; Masayuki Kimura; Annette L Fitzpatrick; Lene Christiansen; Inge Petersen; Clara C Elbers; Tamara Harris; Wei Chen; Sathanur R Srinivasan; Jeremy D Kark; Athanase Benetos; Said El Shamieh; Sophie Visvikis-Siest; Kaare Christensen; Gerald S Berenson; Ana M Valdes; Ana Viñuela; Melissa Garcia; Donna K Arnett; Ulrich Broeckel; Michael A Province; James S Pankow; Candace Kammerer; Yongmei Liu; Michael Nalls; Sarah Tishkoff; Fridtjof Thomas; Elad Ziv; Bruce M Psaty; Joshua C Bis; Jerome I Rotter; Kent D Taylor; Erin Smith; Nicholas J Schork; Daniel Levy; Abraham Aviv
Journal:  Hum Mol Genet       Date:  2012-09-21       Impact factor: 6.150

9.  The MAPK pathway signals telomerase modulation in response to isothiocyanate-induced DNA damage of human liver cancer cells.

Authors:  Evelyn Lamy; Corinna Herz; Sabine Lutz-Bonengel; Anke Hertrampf; Melinda-Rita Márton; Volker Mersch-Sundermann
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence.

Authors:  Lucy Cassar; Craig Nicholls; Alex R Pinto; Ruping Chen; Lihui Wang; He Li; Jun-Ping Liu
Journal:  Protein Cell       Date:  2016-09-30       Impact factor: 14.870

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.